Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
N Engl J Med
.
2017 Mar 16;376(11):1090-1.
doi: 10.1056/NEJMc1700366.
Authors
Eric L Simpson
1
,
Bolanle Akinlade
2
,
Marius Ardeleanu
2
Affiliations
1
Oregon Health and Science University, Portland, OR.
[email protected]
2
Regeneron Pharmaceuticals, Tarrytown, NY
PMID:
28296614
DOI:
10.1056/NEJMc1700366
No abstract available
Publication types
Letter
Kommentar
MeSH terms
Dermatitis, Atopic / drug therapy*
Eczema*
Humans